715 related articles for article (PubMed ID: 30089619)
21. Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors.
Aldrich J; Pundole X; Tummala S; Palaskas N; Andersen CR; Shoukier M; Abdel-Wahab N; Deswal A; Suarez-Almazor ME
Arthritis Rheumatol; 2021 May; 73(5):866-874. PubMed ID: 33258544
[TBL] [Abstract][Full Text] [Related]
22. Pembrolizumab-Induced Fatal Myasthenia, Myocarditis, and Myositis in a Patient with Metastatic Melanoma: Autopsy, Histological, and Immunohistochemical Findings-A Case Report and Literature Review.
Giovannini E; Bonasoni MP; D'Aleo M; Tamagnini I; Tudini M; Fais P; Pelotti S
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446095
[TBL] [Abstract][Full Text] [Related]
23. Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis.
Hamada N; Maeda A; Takase-Minegishi K; Kirino Y; Sugiyama Y; Namkoong H; Horita N; Yoshimi R; Nakajima H;
Front Immunol; 2021; 12():803410. PubMed ID: 34938300
[TBL] [Abstract][Full Text] [Related]
24. Focal myositis: a clinicopathologic study of 115 cases of an intramuscular mass-like reactive process.
Auerbach A; Fanburg-Smith JC; Wang G; Rushing EJ
Am J Surg Pathol; 2009 Jul; 33(7):1016-24. PubMed ID: 19363438
[TBL] [Abstract][Full Text] [Related]
25. Murine MHC-Deficient Nonobese Diabetic Mice Carrying Human HLA-DQ8 Develop Severe Myocarditis and Myositis in Response to Anti-PD-1 Immune Checkpoint Inhibitor Cancer Therapy.
Racine JJ; Bachman JF; Zhang JG; Misherghi A; Khadour R; Kaisar S; Bedard O; Jenkins C; Abbott A; Forte E; Rainer P; Rosenthal N; Sattler S; Serreze DV
J Immunol; 2024 Apr; 212(8):1287-1306. PubMed ID: 38426910
[TBL] [Abstract][Full Text] [Related]
26. A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies.
Guo CW; Alexander M; Dib Y; Lau PKH; Weppler AM; Au-Yeung G; Lee B; Khoo C; Mooney D; Joshi SB; Creati L; Sandhu S
Eur J Cancer; 2020 Jan; 124():15-24. PubMed ID: 31707280
[TBL] [Abstract][Full Text] [Related]
27. Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern.
Matas-García A; Milisenda JC; Selva-O'Callaghan A; Prieto-González S; Padrosa J; Cabrera C; Reguart N; Castrejón N; Solé M; Ros J; Trallero-Araguas E; Antoniol MN; Vila-Pijoan G; Grau JM
Autoimmun Rev; 2020 Feb; 19(2):102455. PubMed ID: 31838162
[TBL] [Abstract][Full Text] [Related]
28. A case report of immune checkpoint inhibitor-related steroid-refractory myocarditis and myasthenia gravis-like myositis treated with abatacept and mycophenolate mofetil.
Jespersen MS; Fanø S; Stenør C; Møller AK
Eur Heart J Case Rep; 2021 Nov; 5(11):ytab342. PubMed ID: 34870082
[TBL] [Abstract][Full Text] [Related]
29. Asymptomatic Myocarditis with Mild Cardiac Marker Elevation Following Nivolumab-Induced Myositis.
Shindo A; Yamasaki M; Uchino K; Yamasaki M
Int Heart J; 2022; 63(1):180-183. PubMed ID: 35095069
[TBL] [Abstract][Full Text] [Related]
30. Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy.
Lucchini M; Bortolani S; Monforte M; Papacci M; Ricci E; Mirabella M; Tasca G
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34011678
[TBL] [Abstract][Full Text] [Related]
31. Pembrolizumab-induced myocarditis with complete atrioventricular block and concomitant myositis in a metastatic bladder cancer patient: a case report and review of the literature.
Saad R; Ghaddar A; Zeenny RM
J Med Case Rep; 2024 Feb; 18(1):107. PubMed ID: 38383436
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
33. Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study.
Fonseca E; Cabrera-Maqueda JM; Ruiz-García R; Naranjo L; Diaz-Pedroche C; Velasco R; Macias-Gómez A; Milisenda JC; Muñoz-Farjas E; Pascual-Goñi E; Gállego Perez-Larraya J; Saiz A; Dalmau J; Blanco Y; Graus F; Martinez-Hernandez E;
Lancet Neurol; 2023 Dec; 22(12):1150-1159. PubMed ID: 37977714
[TBL] [Abstract][Full Text] [Related]
34. Myocarditis as a complication in scleroderma patients with myositis.
Kerr LD; Spiera H
Clin Cardiol; 1993 Dec; 16(12):895-9. PubMed ID: 8168276
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
Mygland A; Vincent A; Newsom-Davis J; Kaminski H; Zorzato F; Agius M; Gilhus NE; Aarli JA
Arch Neurol; 2000 Apr; 57(4):527-31. PubMed ID: 10768628
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic features of myositis patients with CD8-MHC-1 complex pathology.
Ikenaga C; Kubota A; Kadoya M; Taira K; Uchio N; Hida A; Maeda MH; Nagashima Y; Ishiura H; Kaida K; Goto J; Tsuji S; Shimizu J
Neurology; 2017 Sep; 89(10):1060-1068. PubMed ID: 28794251
[TBL] [Abstract][Full Text] [Related]
37. Severe necrotizing myositis associated with long term anti-neoplastic efficacy following nivolumab plus ipilimumab combination therapy.
Tauber M; Cohen R; Laly P; Josselin L; André T; Mekinian A
Clin Rheumatol; 2019 Feb; 38(2):601-602. PubMed ID: 30456528
[TBL] [Abstract][Full Text] [Related]
38. Myocarditis in Patients With Antisynthetase Syndrome: Prevalence, Presentation, and Outcomes.
Dieval C; Deligny C; Meyer A; Cluzel P; Champtiaux N; Lefevre G; Saadoun D; Sibilia J; Pellegrin JL; Hachulla E; Benveniste O; Hervier B
Medicine (Baltimore); 2015 Jul; 94(26):e798. PubMed ID: 26131832
[TBL] [Abstract][Full Text] [Related]
39. Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor-related myocarditis and myositis: rechallenge?
Rossi VA; Gawinecka J; Dimitriou F; von Eckardstein A; Dummer R; Ruschitzka F; Matter CM
ESC Heart Fail; 2023 Aug; 10(4):2680-2685. PubMed ID: 37021424
[TBL] [Abstract][Full Text] [Related]
40. Myositis in primary Sjögren's syndrome: data from a multicentre cohort.
Colafrancesco S; Priori R; Gattamelata A; Picarelli G; Minniti A; Brancatisano F; D'Amati G; Giordano C; Cerbelli B; Maset M; Quartuccio L; Bartoloni E; Carubbi F; Cipriani P; Baldini C; Luciano N; De Vita S; Gerli R; Giacomelli R; Bombardieri S; Valesini G
Clin Exp Rheumatol; 2015; 33(4):457-64. PubMed ID: 26088683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
